Actinium Pharmaceuticals, Inc. Uncategorized Contracts & Agreements

42 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fourth Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan
Actinium Pharmaceuticals, Inc.
Biotechnology
2022
Second Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan
Actinium Pharmaceuticals, Inc.
Biotechnology
2021
Description of securities
Actinium Pharmaceuticals, Inc.
Biotechnology
2021
Amendment to the Actinium Pharmaceuticals, Inc. 2019 Plan
Actinium Pharmaceuticals, Inc.
Biotechnology
2020
Actinium Pharmaceuticals, Inc. 2019 Plan
Actinium Pharmaceuticals, Inc.
Biotechnology
2020
Indemnity Agreement, dated April 27, 2018, by and between Jeffrey W. Chell and Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc.
Biotechnology
DE
2018
Director Agreement, dated April 27, 2018, by and between Jeffrey W. Chell and Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2018
Offer Letter, effective January 31, 2018, between Anil Kapur and Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2018
Offer Letter, effective January 2, 2018, between Dale L. Ludwig and Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2018
Dealer-Manager Agreement, dated February 15, 2018, between Maxim Group LLC and Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2018
Agreement, dated June 6, 2017, by and between Actinium Pharmaceuticals, Inc. and Sergio Traversa
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2017
Offer Letter; dated May 26, 2017, by and between Actinium Pharmaceuticals, Inc. and Dr. Nitya G. Ray
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2017
Indemnity Agreement, dated May 15, 2017, by and between Actinium Pharmaceuticals, Inc. and Steve OLoughlin
Actinium Pharmaceuticals, Inc.
Biotechnology
DE
2017
INDEMNIFICATIONAGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
DE
2017
INDEMNIFICATIONAGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
DE
2017
ACTINIUMPHARMACEUTICALS, INC. 8,000,000 Shares CommonStock ($0.001par value) UnderwritingAgreement
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2016
Effective Date: August 6, 2015
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2015
SUBSCRIPTIONAGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2015
AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2015
ACTINIUMPHARMACEUTICALS, INC. AMENDED AND RESTATED 2013 EQUITYINCENTIVE PLAN
Actinium Pharmaceuticals, Inc.
Biotechnology
DE
2015
EffectiveDate: August 11, 2014
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2015
To subscribe for Units in the private offering of ACTINIUM PHARMACEUTICALS, INC.
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2014
FORM OF LOCK-UP AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
2014
LOCK-UP LETTER AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
CLINICAL TRIAL AGREEMENT (SK#11731)
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
Sloan-Kettering Institute for Cancer Research 1275 York Avenue New York, NY 10021
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
AMENDMENT No. 1 TO RESEARCH AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
CLINICAL TRIAL AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
TX
2013
Proposal for Actinium Pharmaceuticals, Inc. 225Ac-Labeling of HuM195 March 30, 2007
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
Project Agreement Number: 1 Aptiv Project Number: ACTI-1903
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
CLINICAL TRIAL AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
CLINICAL TRIAL AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
CLINICAL TRIAL AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
Actinium Pharmaceuticals, Inc. July 21, 2012
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2013
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2013
CLINICAL TRIAL AGREEMENT
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
An Operating Division of Averion International Corp. *CONFIDENTIAL*
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2013
Monday, April 14, 2003 (3).max
Actinium Pharmaceuticals, Inc.
Biotechnology
2013
LAIDLAW & COMPANY (UK) LTD. 90 Park Avenue41 Dover StreetNew York, NY 10016W1S 4NS London * Member FINRA, SIPC* *Incorporated in England & Wales: Company No. 3870324* *Authorized...
Actinium Pharmaceuticals, Inc.
Biotechnology
NY
2013